VFA
AVDL

Valeo Financial Advisors’s Avadel Pharmaceuticals AVDL Stock Holding History

Valeo Financial Advisors’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-71,000
Closed -$356K – 565
2022
Q3 		$356K Buy
71,000
+26,000
+58% +$143K 0.02% 307
2022
Q2 		$110K Buy
+45,000
New +$185K 0.01% 456
2021
Q4 		– Sell
-10,000
Closed -$98K – 600
2021
Q3 		$98K Buy
+10,000
New +$78.7K 0.01% 532

Other funds holding AVDL

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TLP
Tri Locum Partners New York $713M AUM 68.92% 1-Year Est. Return

Valeo Financial Advisors's AVDL Position: Q4 2022 in Review

Valeo Financial Advisors sold out of Avadel Pharmaceuticals (AVDL) in Q4 2022, closing a stake of 71,000 shares — an estimated $356K sold.

Valeo Financial Advisors first reported a position in AVDL in Q3 2021 and held it in 3 quarters. The position peaked at $356K in Q3 2022. 83 funds tracked by Wall St. Rank hold AVDL as of Q4 2022.

  • Valeo Financial Advisors reported no remaining Avadel Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Valeo Financial Advisors sold 71,000 Avadel Pharmaceuticals shares in Q4 2022, an estimated $356K.
  • Valeo Financial Advisors first reported a position in Avadel Pharmaceuticals in Q3 2021 and held it in 3 quarters.
  • Valeo Financial Advisors's Avadel Pharmaceuticals position peaked at $356K in Q3 2022.
  • 83 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2022.

Based on Valeo Financial Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.